Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 870)
Posted On: 08/04/2025 7:31:31 PM
Post# of 155732
Posted By: My69z
"The decline in circulating tumor cells (“CTCs”) observed in most patients after as little as **....one dose of leronlimab**..... was significantly associated with both progression-free and overall survival.

& .....

"Confirming the full extent of leronlimab’s activity on the primary tumor is on our short list of clinical priorities in the coming months."
___
That....is why the recent filings

Just like I said on 7/27/2025:

https://investorshangout.com/post/view?id=6779023

There is no way we do not prove & get historically credited with the MOA that has changed humanity.













(17)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site